Skip to content
10-K

Annual Report

ACRO BIOMEDICAL CO., LTD. ACBM

0001640334-23-001347

← back to feed
Filed
Jul 21, 2023 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2022 · Jul 17, 2023 60.04M sh
Operating Cash Flow FY 2022 · Dec 31, 2021 $299.34K
Current Liabilities FY 2022 · Dec 31, 2021 $91.65K
Total Liabilities FY 2022 · Dec 31, 2021 $117.37K
Current Assets FY 2022 · Dec 31, 2021 $706.42K
Total Assets FY 2022 · Dec 31, 2021 $761.08K
Sga Expense FY 2022 · Dec 31, 2021 $2.67M
Rd Expense FY 2022 · Dec 31, 2021 $5.29M
Net Income FY 2022 · Dec 31, 2021 −$7.7M
Operating Income FY 2022 · Dec 31, 2021 −$7.69M
Gross Profit FY 2022 · Dec 31, 2021 $259.5K
Cost Of Revenue FY 2022 · Dec 31, 2021 $938K
Revenue FY 2022 · Dec 31, 2021 $1.2M
Stockholders Equity FY 2022 · Dec 31, 2020 $685.87K